A Massive, Underserved Market
The Global Mental Health Crisis
Multiple High-Growth Markets
Market Opportunity
Neurotechnology Market
EEG systems, brain stimulation devices, and neuromodulation technologies
Mental Health Market
Clinical services, therapy, and treatment solutions
Medical Education Market
Professional training, CME programs, and certification courses
Diversified Revenue Streams
Three-Pillar Business Model
Technologies
Medical-grade neurotechnology hardware and software
- Synapse™ EEG acquisition systems
- Axion™ neuromodulation devices
- Orion™ navigation systems
- Lumina™ AI analytics platform
Studio (Metis Academy)
Professional training and certification programs
- Online and in-person courses
- CME-accredited certifications
- Institutional partnerships
- Subscription-based learning platform
Floren Neuro Clinic
Clinical mental health services
- Evidence-based treatment protocols
- Technology-enhanced therapy
- Corporate wellness programs
- Franchise model for scaling
Why Metis Scientific Leads
Competitive Advantages
Regulatory Approval
Medical-grade devices with clinical validation. Regulatory certification (MDR/CE) and FDA clearance are currently in progress.
Proprietary Technology
Patented AI algorithms for qEEG analysis, early dementia detection, and personalized treatment protocols.
Clinical Validation
Proven efficacy in 50+ clinical studies across leading research institutions including Max Planck Institute and Charité Berlin.
Scalable Model
Three complementary revenue streams with 70%+ gross margins. Franchise-ready clinic model for rapid expansion.
First-Mover Advantage
Only integrated neuroscience ecosystem combining hardware, software, training, and clinical services.
Strong Pipeline
$8.2M in qualified leads, partnerships with 12 major hospitals, and expanding distribution network across Europe.
Series A Funding Round
Investment Highlights
Use of Funds
Enhance AI capabilities, expand product line
Scale distribution, enter new markets
Open 3 new locations, build franchise model
Hire key executives and specialists
Operations and inventory
Projected Returns
Based on conservative revenue projections and comparable exits
Building the Foundations for Cognitive Autonomy
A disciplined, 6-phase journey from clinical legitimacy to human-AI cognitive boundaries
Our Guiding Principle
Every phase is commercially viable on its own — if we stop after Phase 1, we have built a successful MedTech company. Each phase builds clinical credibility, high-quality data, and trust before advancing. We move with scientific rigor, regulatory discipline, and an unwavering commitment to human agency.
Interested in partnering or collaborating?
